サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1761162

バイオ医薬品受託製造市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：製品タイプ別、供給源別、用途別、治療分野別、地域別

Biopharmaceutical Contract Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Source, Application, Therapeutic Area, and Geography

出版日
ページ情報
英文 243 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
バイオ医薬品受託製造市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：製品タイプ別、供給源別、用途別、治療分野別、地域別
出版日: 2025年06月17日
発行: The Insight Partners
ページ情報: 英文 243 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品受託製造市場規模は、2024年の409億9,000万米ドルから2031年には1,010億5,000万米ドルに成長すると予測されており、2025～2031年のCAGRは13.8%と予測されています。生物製剤に対する需要の高まり、コスト効率と柔軟性に対する需要の高まりは、バイオ医薬品受託製造市場規模の拡大に寄与する注目すべき要因です。しかし、予算の逼迫と経済の不確実性がバイオ医薬品受託製造市場の成長を妨げています。

モノクローナル抗体、遺伝子治療、細胞ベースの治療は、より革新的で合理的な製造プロセスの必要性を生み出しています。その結果、製造受託機関（CMO）は、連続製造、自動化、人工知能（AI）、プロセス分析技術（PAT）などの先進技術を採用し、生産能力を強化し、バイオ医薬品の需要増に対応する動きが加速しています。連続製造は、生物製剤の連続生産を可能にし、一貫性、スピード、効率を高めることから、バイオ医薬品業界で急速に普及しています。このプロセスにより、製造工程間のダウンタイムが短縮され、中間貯蔵の必要性が最小限に抑えられるため、製造コストが大幅に削減されます。ベーカー・マッケンジーの報告書によれば、連続製造は生物製剤の製造コストを30％削減できます。ノバルティスとファイザーは、大規模な生物学的製剤の製造に連続製造を導入している大手企業のひとつであり、業務効率の改善とコスト削減に有効であることを示しています。

人工知能（AI）はプロセスの最適化、予知保全、品質管理にも利用できます。AIベースのツールは、膨大な量の生産データをリアルタイムで分析し、潜在的な問題が発生する前に特定し、生産プロセス全体を通じて最適な状態を確保することができます。この技術は、CMOがダウンタイムを最小限に抑え、歩留まり率を向上させるのに役立ちます。コグニザントのような企業は、すでにAIを使って製造プロセスにおける潜在的な不具合を予測し、意思決定を改善しています。さらに、プロセス分析技術（PAT）は、重要なプロセスパラメーターのリアルタイムモニタリングと制御を可能にし、生物製剤の大規模バッチ全体で一貫した品質を保証します。PATを統合することで、メーカーは製造工程の早い段階でばらつきを検出し、欠陥や不整合を防ぐためにリアルタイムで調整することができます。その結果、製品の品質が向上し、リソースをより効率的に使用できるようになり、時間とコストの両方が削減されます。したがって、連続製造、自動化、AI、PATなどの高度な製造技術の採用が増加していることは、今後数年間のバイオ医薬品受託製造市場の成長に寄与すると予想されます。

治療領域ベースの洞察

治療分野に基づき、バイオ医薬品受託製造市場は、腫瘍学、自己免疫疾患、呼吸器疾患、代謝疾患、神経学、感染症、その他に区分されます。2024年のバイオ医薬品受託製造市場シェアは、がん分野が最大でした。がんは依然として世界の死因のトップであるため、先進的ながん治療へのニーズが高まっています。世界保健機関（WHO）によると、2022年には世界で2,000万人の新規がん患者と970万人のがん関連死が報告されました。この需要は主に生物学的製剤の開発によってもたらされており、生物学的製剤の製造には複雑な細胞培養システムと厳格な品質管理措置が必要であるため、多くの製薬企業にとって製造委託先へのアウトソーシングは実行可能なソリューションとなっています。キイトルーダは2024年に294億8,000万米ドルの売上高を記録し、がん生物学的製剤の巨大な市場ポテンシャルを浮き彫りにしました。さらに、特にKymriah（tisagenlecleucel）やYescarta（axicabtagene ciloleucel）などのCAR-T療法を中心とした個別化腫瘍治療への傾向の高まりも、高度に専門化された受託製造の必要性に拍車をかけています。これらの治療には遺伝子組み換え免疫細胞の生産が必要であり、細胞治療や遺伝子治療に精通したCMOへの需要が生まれ、バイオ医薬品受託製造市場の成長に拍車をかけています。

世界保健機関（WHO）、世界自己免疫研究所（Global Autoimmune Institute 2022）報告書、国際糖尿病連合（International Diabetes Federation）などは、バイオ医薬品受託製造市場レポート作成時に参照した一次情報および二次情報です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ
  • 仮定と限界

第4章 バイオ医薬品受託製造市場の情勢

  • PEST分析

第5章 バイオ医薬品受託製造市場：主要市場力学

  • バイオ医薬品受託製造市場：主要市場力学
  • 市場促進要因
    • 生物製剤に対する需要の高まり
    • コスト効率と柔軟性への要求の高まり
  • 市場抑制要因
    • 予算の逼迫と経済の不確実性
  • 市場機会
    • 個別化医療への需要の高まり
  • 今後の動向
    • 先進製造技術
  • 促進要因と抑制要因の影響

第6章 バイオ医薬品受託製造市場- 世界市場分析

  • バイオ医薬品受託製造市場の収益、2021年～2031年
  • バイオ医薬品受託製造市場の予測分析

第7章 バイオ医薬品受託製造市場分析-製品タイプ別

  • 生物製剤
  • バイオシミラー

第8章 バイオ医薬品受託製造市場分析-供給源別

  • 微生物
  • 哺乳類

第9章 バイオ医薬品受託製造市場分析-用途別

  • 商業用
  • 臨床用

第10章 バイオ医薬品受託製造市場の分析-治療分野別

  • がん領域
  • 自己免疫疾患
  • 呼吸器疾患
  • 代謝疾患
  • 神経学
  • 感染症
  • その他

第11章 バイオ医薬品受託製造市場：地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第12章 競合情勢

  • 主要企業によるヒートマップ分析
  • 企業のポジショニングと集中度

第13章 業界情勢

  • 事業拡大
  • 新製品開発
  • 合併と買収
  • パートナーシップ
  • その他の事業戦略

第14章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Lonza Group AG
  • Samsung Biologics Co Ltd
  • Merck KGaA
  • AbbVie Inc
  • WuXi Biologics Inc
  • Ajinomoto Co Inc
  • Cytiva
  • AGC Biologics AS

第15章 付録

図表

List Of Tables

  • Table 1. Biopharmaceutical Contract Manufacturing Market Segmentation
  • Table 2. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 3. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 4. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 5. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 6. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 9. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 10. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 11. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 12. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 13. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 14. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 15. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 16. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 17. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 18. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 19. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 20. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 21. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 22. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 23. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 24. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 25. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 26. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 28. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 29. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 30. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 31. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 32. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 33. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 34. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 35. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 36. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 37. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 38. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 41. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 42. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 43. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 44. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 45. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 46. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 47. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 48. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 49. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 50. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 51. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 52. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 53. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 54. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 55. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 56. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 57. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 58. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 59. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 60. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 61. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 62. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 65. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 66. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 67. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 68. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 69. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 70. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 71. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 72. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 73. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 74. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 75. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 76. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 77. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 78. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 79. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 80. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 81. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 82. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 83. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 84. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 85. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 86. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 87. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 88. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 89. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 90. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 91. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 92. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 93. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 94. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 95. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 96. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 97. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 98. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 99. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 100. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 101. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 102. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 103. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 104. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 105. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 106. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 107. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 108. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 109. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 110. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 111. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 112. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 113. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 114. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 115. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 116. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 117. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 118. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 119. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 120. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 121. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 122. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 123. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 124. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 125. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 126. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 127. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 128. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 129. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 130. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 131. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 132. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 133. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 134. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 135. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 136. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 137. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 138. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 139. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 140. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 141. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 142. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 143. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 144. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 145. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 146. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 147. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 148. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 149. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 150. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 151. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 152. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 153. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 154. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 155. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 156. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 157. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 158. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 159. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 160. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 161. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 162. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 163. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 164. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 165. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 166. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 167. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 168. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 169. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 170. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 171. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 172. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 173. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 174. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 175. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 176. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 177. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 178. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 179. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 180. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 181. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 182. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 183. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 184. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 185. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 186. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 187. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 188. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 189. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 190. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 191. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 192. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 193. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 194. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 195. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 196. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 197. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 198. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 199. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 200. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 201. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 202. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 203. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 204. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 205. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 206. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 207. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 208. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 209. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 210. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 211. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 212. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 213. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 214. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 215. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 216. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 217. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 218. Heat Map Analysis by Key Players
  • Table 219. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

List Of Figures

  • Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 5. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 6. Biopharmaceutical Contract Manufacturing Market Share (%) - by Product Type (2024 and 2031)
  • Figure 7. Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Biopharmaceutical Contract Manufacturing Market Share (%) - by Source (2024 and 2031)
  • Figure 10. Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Biopharmaceutical Contract Manufacturing Market Share (%) - by Application (2024 and 2031)
  • Figure 13. Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Biopharmaceutical Contract Manufacturing Market Share (%) - by Therapeutic Area (2024 and 2031)
  • Figure 16. Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 24. North America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 25. United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 29. Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 30. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 38. China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 45. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 51. South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Company Positioning & Concentration
目次
Product Code: TIPRE00005512

The biopharmaceutical contract manufacturing market size is expected to grow from US$ 40.99 billion in 2024 to US$ 101.05 billion by 2031; it is projected to register a CAGR of 13.8% during 2025-2031. Rising demand for biologics and increasing demand for cost efficiency and flexibility are noteworthy factors contributing to the expansion of the biopharmaceutical contract manufacturing market size. However, the tightened budget and economic uncertainty hinder the biopharmaceutical contract manufacturing market growth.

Monoclonal antibodies, gene therapies, and cell-based treatments have created the need for more innovative, streamlined manufacturing processes. As a result, contract manufacturing organizations (CMOs) are increasingly adopting advanced technologies such as continuous manufacturing, automation, artificial intelligence (AI), and process analytical technologies (PAT) to enhance production capabilities and meet the growing demand for biopharmaceuticals. Continuous manufacturing is rapidly gaining traction in the biopharmaceutical industry as it allows the uninterrupted production of biologics, providing greater consistency, speed, and efficiency. This process reduces downtime between production runs and minimizes the need for intermediate storage, significantly reducing production costs. According to a Baker McKenzie report, continuous manufacturing can reduce the cost of biologic production by 30%. Novartis and Pfizer are among the major companies implementing continuous manufacturing for large-scale biologic production, demonstrating its effectiveness in improving operational efficiency and reducing costs.

Artificial intelligence (AI) can also be used for process optimization, predictive maintenance, and quality control. AI-based tools can analyze vast amounts of production data in real-time, identifying potential issues before they arise and ensuring optimal conditions throughout the production process. This technology helps CMOs minimize downtime and improve yield rates. Companies such as Cognizant are already using AI to predict potential failures in manufacturing processes and improve decision-making. Furthermore, process analytical technologies (PAT) enable real-time monitoring and control of critical process parameters, ensuring consistent quality across large batches of biologics. By integrating PAT, manufacturers can detect variations early in the production process and adjust in real-time to prevent defects or inconsistencies. This results in higher-quality products and more efficient use of resources, reducing both time and cost. Therefore, the increasing adoption of advanced manufacturing technologies such as continuous manufacturing, automation, AI, and PAT is expected to contribute to the growth of the biopharmaceutical contract manufacturing market in the coming years.

Therapeutic Area-Based Insights

Based on the therapeutic area, the biopharmaceutical contract manufacturing market is segmented into oncology, autoimmune disorders, respiratory disorders, metabolic disorders, neurology, infectious diseases, and others. The oncology segment held the largest biopharmaceutical contract manufacturing market share in 2024. As cancer remains a leading cause of death globally, it drives the need for advanced cancer treatments. According to the World Health Organization (WHO), 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. This demand is primarily driven by the development of biologics and the production of biologics involves complex cell culture systems and stringent quality control measures, making outsourcing to contract manufacturers a viable solution for many pharmaceutical companies. Keytruda generated US$ 29.48 billion in sales in 2024, highlighting the immense market potential of oncology biologics. Additionally, the increasing trend toward personalized oncology treatments, particularly with CAR-T therapies such as Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel), has also fueled the need for highly specialized contract manufacturing. These treatments require the production of genetically modified immune cells, which creates the demand for CMOs with expertise in cell and gene therapies, thereby fueling the biopharmaceutical contract manufacturing market growth.

World Health Organization (WHO), Global Autoimmune Institute 2022 report, and International Diabetes Federation are among the primary and secondary sources referred to while preparing the biopharmaceutical contract manufacturing market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Biopharmaceutical Contract Manufacturing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics

  • 5.1 Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Rising Demand for Biologics
    • 5.2.2 Increasing Demand for Cost Efficiency and Flexibility
  • 5.3 Market Restraints
    • 5.3.1 Tightened Budget and Economic Uncertainty
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Demand for Personalized Medicine
  • 5.5 Future Trends
    • 5.5.1 Advanced Manufacturing Technologies
  • 5.6 Impact of Drivers and Restraints:

6. Biopharmaceutical Contract Manufacturing Market - Global Market Analysis

  • 6.1 Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • 6.2 Biopharmaceutical Contract Manufacturing Market Forecast Analysis

7. Biopharmaceutical Contract Manufacturing Market Analysis - by Product Type

  • 7.1 Biologics
    • 7.1.1 Overview
    • 7.1.2 Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Biosimilar
    • 7.2.1 Overview
    • 7.2.2 Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. Biopharmaceutical Contract Manufacturing Market Analysis - by Source

  • 8.1 Microbial
    • 8.1.1 Overview
    • 8.1.2 Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Mammalian
    • 8.2.1 Overview
    • 8.2.2 Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. Biopharmaceutical Contract Manufacturing Market Analysis - by Application

  • 9.1 Commercial
    • 9.1.1 Overview
    • 9.1.2 Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Clinical
    • 9.2.1 Overview
    • 9.2.2 Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. Biopharmaceutical Contract Manufacturing Market Analysis - by Therapeutic Area

  • 10.1 Oncology
    • 10.1.1 Overview
    • 10.1.2 Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Autoimmune Disorders
    • 10.2.1 Overview
    • 10.2.2 Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Respiratory Disorders
    • 10.3.1 Overview
    • 10.3.2 Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Metabolic Disorders
    • 10.4.1 Overview
    • 10.4.2 Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Neurology
    • 10.5.1 Overview
    • 10.5.2 Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Infectious Diseases
    • 10.6.1 Overview
    • 10.6.2 Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

11. Biopharmaceutical Contract Manufacturing Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Biopharmaceutical Contract Manufacturing Market Overview
    • 11.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.1.2.1 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.1.2.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.1.2.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.1.2.4 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.1.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.1.1 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.1.2 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.1.3 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.1.4 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.1.3.2 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.2.1 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.2.2 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.2.3 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.2.4 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.1.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.2 Europe
    • 11.2.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
    • 11.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.2.2.1 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.2.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.2.2.4 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.1.1 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.1.2 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.1.3 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.1.4 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.2.1 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.2.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.2.3 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.2.4 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.3 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.3.1 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.3.2 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.3.3 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.3.4 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.4 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.4.1 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.4.2 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.4.3 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.4.4 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.5 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.5.1 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.5.2 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.5.3 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.5.4 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Biopharmaceutical Contract Manufacturing Market Overview
    • 11.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.3.2.1 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.3.2.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.3.2.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.1.1 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.1.2 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.1.3 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.1.4 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.2 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.2.1 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.2.2 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.2.3 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.2.4 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.3 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.3.1 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.3.2 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.3.3 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.3.4 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.4 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.4.1 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.4.2 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.4.3 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.4.4 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.5 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.5.1 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.5.2 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.5.3 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.5.4 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.6 Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.6.1 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.6.2 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.6.3 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.6.4 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.4 Middle East & Africa
    • 11.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Overview
    • 11.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.4.2.1 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.4.2.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.2.1 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.2.2 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.2.3 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.2.4 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.3.1 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.3.2 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.3.4 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.4.1 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.4.2 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.4.3 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.4.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.5 South & Central America
    • 11.5.1 South & Central America Biopharmaceutical Contract Manufacturing Market Overview
    • 11.5.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.5.2.1 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.5.2.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.4 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.5.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.5.3.2 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.5.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.3.1 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.3.2 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.3.4 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning & Concentration

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Expansion
  • 13.3 New Product Development
  • 13.4 Merger and Acquisition
  • 13.5 Partnerships
  • 13.6 Other Business Strategies

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lonza Group AG
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Samsung Biologics Co Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 AbbVie Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 WuXi Biologics Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ajinomoto Co Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Cytiva
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AGC Biologics AS
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms